awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39008777-3451B3E1-4605-41F4-B06C-56C5F326BA74
Q39008777-3451B3E1-4605-41F4-B06C-56C5F326BA74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39008777-3451B3E1-4605-41F4-B06C-56C5F326BA74
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study.
P2860
Q39008777-3451B3E1-4605-41F4-B06C-56C5F326BA74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39008777-3451B3E1-4605-41F4-B06C-56C5F326BA74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd92718b1fe0ad4355acca9bb51338f9a1383cd3
P2860
Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.